Rain Oncology Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rain Oncology Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2023.
  • Rain Oncology Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $1.23M, a 31.8% increase year-over-year.
  • Rain Oncology Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $4.9M, a 0.7% increase year-over-year.
  • Rain Oncology Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.86M, a 57% increase from 2021.
  • Rain Oncology Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.09M, a 257% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $4.9M $1.23M +$296K +31.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.6M $837K -$580K -40.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.18M $1.57M +$326K +26.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.86M $1.26M -$8K -0.63% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-09
Q3 2022 $4.86M $932K +$70K +8.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.79M $1.42M +$624K +78.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.17M $1.24M +$1.08M +653% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.09M $1.27M +$1M +373% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $2.09M $862K +$661K +329% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.43M $793K +$597K +305% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $831K $165K -$34K -17.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $865K $269K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $201K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $196K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $199K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.